Adrenomed AG: Adrecizumab is Safe, Well-tolerated and Shows Additional...

Phase-I study demonstrates excellent tolerability and safety of Adrecizumab in healthy subjects. Adrenomed AG plans second Phase-II study in acute heart failure, in addition to septic shock.(PRWeb March 08, 2017)Read the full story at http://www.prweb.com/releases/2017/03/prweb14127485.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news